Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1

Clinical trial NCT03610022 · COMPLETED

Trial details

NCT number: NCT03610022
Sponsor: University Hospital, Bordeaux
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Metastatic Basal Cell Carcinoma Locally Advanced Basal Cell Carcinoma

Start date: 2018-09-03
Primary completion: 2021-05-12
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.